MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/lbr.0000000000001094

Медицинская библиотека · Journal of bronchology & interventional pulmonology · 2026

Diagnostic and Molecular Yield of a Multidisciplinary Team-Guided Combined Endobronchial and Endoscopic Ultrasound-Guided Sampling Strategy for Mediastinal and Hilar Lymphadenopathy.

Abdelsamad Ahmed, Alghunaim Essa, Mokhtar Mahmoud, Zaglouol Hossam, Sabry Essam, Al Saeed Talal, Alhajri Reem, Alrefae Nusaiba, Majumdar Kaushik, AlBaqer Tahani, Ahmed Amir A, Alshehab Dherar, Ayed Adel, Ghanbar Mohammad I, Khadadah Sulaiman

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Real-world data examining structured modality selection for mediastinal/hilar adenopathy in mixed malignant and benign cohorts is limited. We evaluated the performance of a multidisciplinary team (MDT)-guided strategy incorporating EBUS/EUS-B and EUS for both benign and malignant disease.

METHODS

We conducted a retrospective study, including consecutive adults undergoing mediastinal/hilar lymph node sampling by endoscopy after MDT discussion. All cases were discussed at a dedicated thoracic MDT before the procedure, where the indication for sampling and the modality were predetermined based on anatomic accessibility on CT/PET-CT, clinical data, and anticipated tissue requirements. The primary outcome was diagnostic yield, defined as the proportion of procedures providing a definitive pathologic diagnosis consistent with the clinical and radiologic context, with concordance for benign diagnoses confirmed by a minimum of 3 months of clinical and radiologic follow-up. Secondary outcomes included yield by indication, modality, and adequacy of molecular testing.

RESULTS

Among 213 patients (64.3% male; mean age 56±14.5 y), the overall diagnostic yield was 92%. Indications for biopsy comprised 134 suspected carcinomas and 79 suspected benign or lymphoproliferative cases. Diagnostic yield was 91.8% (n=123/134) in suspected carcinoma and 92.4% (n=73/79) in suspected benign or lymphoproliferative disease. Molecular testing was processed in 57 malignant cases, with 89.5% successful completion.

CONCLUSION

A structured, MDT-driven endosonographic strategy was associated with high diagnostic and molecular adequacy in this cohort of malignant and benign mediastinal/hilar lymphadenopathy. Given the nonrandomized design and small sample size, findings should be interpreted cautiously. Prospective studies are warranted to further define the optimal role of each modality.

Для цитирования: Abdelsamad Ahmed, Alghunaim Essa, Mokhtar Mahmoud, Zaglouol Hossam, Sabry Essam, Al Saeed Talal, Alhajri Reem, Alrefae Nusaiba, Majumdar Kaushik, AlBaqer Tahani, Ahmed Amir A, Alshehab Dherar, Ayed Adel, Ghanbar Mohammad I, Khadadah Sulaiman. Diagnostic and Molecular Yield of a Multidisciplinary Team-Guided Combined Endobronchial and Endoscopic Ultrasound-Guided Sampling Strategy for Mediastinal and Hilar Lymphadenopathy.. Journal of bronchology & interventional pulmonology. 2026. DOI: 10.1097/lbr.0000000000001094.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.